New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps
Recursion official investor newsroom · 行業原文收錄 · 來源發佈:Mon Nov 02 2026 21:35:09 GMT+0000 (Coordinated Universal Time) · 本站收錄:Mon Nov 02 2026 22:08:25 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps November 2, 2026 at 4:25 PM EST PDF Version Updated TUPELO results featured in a Presidential Plenary at CGA-IGC : Lisa Boardman , M.D., Professor of Medicine at Mayo Clinic , presented updated findings from the Phase 1b/2 TUPELO tria
以上為帶出處的原文節選,完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。